Loading...
XSHE
002817
Market cap306mUSD
Jun 11, Last price  
7.38CNY
1D
0.14%
1Q
13.02%
Jan 2017
-55.30%
IPO
15.82%
Name

Anhui Huangshan Capsule Co Ltd

Chart & Performance

D1W1MN
P/E
44.82
P/S
4.66
EPS
0.16
Div Yield, %
1.15%
Shrs. gr., 5y
—
Rev. gr., 5y
7.78%
Revenues
473m
+2.31%
189,446,728244,009,476268,953,187273,413,371253,790,897283,435,099285,955,869294,709,587325,557,296319,426,287379,891,008428,318,791462,771,215473,483,218
Net income
49m
-24.07%
37,344,84847,936,67847,983,29851,761,10554,890,45852,284,78146,420,39035,966,20839,130,70245,255,71056,887,81160,850,37264,863,46749,253,369
CFO
64m
-36.40%
22,936,30065,695,80023,126,72552,066,50540,324,01732,526,93844,423,82427,523,87952,028,24362,711,55786,089,40683,016,82099,856,43663,511,120
Dividend
Jun 27, 20240.085 CNY/sh

Profile

Anhui Huangshan Capsule Co., Ltd. manufactures and sells hollow and enteric hollow capsules in China. It offers entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colon soluble vacant gelatin capsules, hydroxypropyl methyl cellulose and hydroxypropyl starch hollow capsules, and pulluan capsules. The company was founded in 1989 and is based in Xuancheng, China.
URL
http://www.hsjn.com/
IPO date
Oct 25, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
473,483
2.31%
462,771
8.04%
428,319
12.75%
Cost of revenue
397,254
376,323
360,282
Unusual Expense (Income)
NOPBT
76,229
86,449
68,036
NOPBT Margin
16.10%
18.68%
15.88%
Operating Taxes
9,379
6,832
Tax Rate
12.30%
7.90%
NOPAT
66,850
79,617
68,036
Net income
49,253
-24.07%
64,863
6.60%
60,850
6.97%
Dividends
(18,037)
(17,091)
Dividend yield
0.70%
0.64%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,912
274
Long-term debt
44
10,221
274
Deferred revenue
13,882
30,095
31,203
Other long-term liabilities
1
1
Net debt
(341,598)
(233,477)
(370,094)
Cash flow
Cash from operating activities
63,511
99,856
83,017
CAPEX
(6,582)
Cash from investing activities
(208,066)
Cash from financing activities
(7,106)
FCF
99,567
105,578
58,321
Balance
Cash
341,642
243,759
370,641
Long term investments
2
1,851
Excess cash
317,968
222,471
349,225
Stockholders' equity
763,113
752,004
769,063
Invested Capital
613,698
720,560
527,744
ROIC
10.02%
12.76%
13.04%
ROCE
8.15%
9.12%
7.71%
EV
Common stock shares outstanding
299,098
294,834
299,098
Price
6.26
-28.54%
8.76
-2.23%
8.96
4.01%
Market cap
1,872,355
-27.51%
2,582,745
-3.63%
2,679,920
4.01%
EV
1,532,079
2,349,905
2,310,278
EBITDA
122,238
132,330
111,108
EV/EBITDA
12.53
17.76
20.79
Interest
28
24
2,047
Interest/NOPBT
0.04%
0.03%
3.01%